Michael S. Ball

CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages

K. Liby, P. Pioli, Michael S. Ball, 2016, PloS one.

Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.

A. M. Houghton, P. Grandi, M. Weller, 2019, JCI insight.

Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin.

Jaclyn N. Taroni, Tammara A. Wood, Jennifer M. Franks, 2018, The Journal of investigative dermatology.

ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity

B. Haines, C. Quéva, L. Lerner, 2020, Cancer Immunology Research.

Profibrotic Activation of Human Macrophages in Systemic Sclerosis

M. Whitfield, E. Schaafsma, Mohamed A ElTanbouly, 2020, Arthritis & rheumatology.

139 Chimeric antigen receptor macrophages (CAR-M) elicit a systemic anti-tumor immune response and synergize with PD1 blockade in immunocompetent mouse models of HER2+ solid tumors

M. Klichinsky, T. Condamine, S. Abramson, 2021, Journal for ImmunoTherapy of Cancer.

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

M. Whitfield, Mohamed A ElTanbouly, K. Liby, 2020, Scientific Reports.

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

M. Whitfield, Mohamed A ElTanbouly, K. Liby, 2020, Scientific Reports.